Inter Miami CF Renews Longstanding Multilayered Partnership with Baptist Health  - Scorecard - MDSpire

Inter Miami CF Renews Longstanding Multilayered Partnership with Baptist Health 

Baptist Health Continues Partnership as Inter Miami CF’s Official Medical Team and becomes a Founding Partner of Miami Freedom Park

  • March 18, 2026

  • 4 min

Share

Clinical Scorecard: Inter Miami CF Renews Longstanding Multilayered Partnership with Baptist Health

At a Glance

CategoryDetail
ConditionCommunity Health and Sports Medicine
Key MechanismsPartnership for medical care and community engagement through sports
Target PopulationInter Miami CF players, fans, and local community members
Care SettingSports teams and community health initiatives

Key Highlights

  • Baptist Health continues as the Official Medical Team for Inter Miami CF.
  • Partnership includes support for youth sports through the Inter Miami CF Academy.
  • Baptist Health Sports Fields and Family Fan Zone enhance community engagement.
  • Commitment to health initiatives and community connection through events.
  • Baptist Health recognized as a leader in healthcare in South Florida.

Guideline-Based Recommendations

Diagnosis

  • Utilize sports medicine expertise for player health assessments.

Management

  • Provide orthopedic care and medical support for athletes.

Monitoring & Follow-up

  • Regular health check-ups and injury assessments for players.

Risks

  • Address potential injuries and health issues in athletes.

Patient & Prescribing Data

Athletes and community members engaging in sports activities.

Focus on sports medicine and community health initiatives.

Clinical Best Practices

  • Engage in community health events to promote wellness.
  • Collaborate with local organizations to enhance health outreach.
  • Implement regular health screenings for athletes.

Related Resources & Content

Original Source(s)

Inter Miami CF Renews Longstanding Multilayered Partnership with Baptist Health 

  • March 18, 2026

Related Content

The importance of robust genomic testing for patients

Misako Nagasaka, MD, PhD shared how precision oncology has fundamentally shifted the landscape through the identification of actionable genomic targets for lung cancer treatment.

  • June 25, 2026

  • 1 min
This Week’s CGT News: Radiopharmaceutical Boosts CAR T

A targeted radiopharmaceutical improves CAR T activity in neuroblastoma models, engineered Tregs suppress allergic asthma, and new gene therapy platforms target MMA and the brain

  • July 13, 2026

  • 5 min
2026 ASCO Prostate Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates.

  • July 2, 2026

  • 1 min